Lanluma V

Product Overview

Lanluma V is an advanced injectable treatment designed to stimulate the body's natural collagen production, leading to long-lasting volume and improved skin texture. Manufactured by Sinclair Pharma, Lanluma V utilizes Poly-L-lactic acid (PLLA) microparticles to restore a youthful appearance by gradually rebuilding the skin's structural framework from within. It is specifically formulated for aesthetic treatments requiring significant volumization and deep dermal correction on both face and body.

This professional-use medical device is intended for administration by trained healthcare practitioners to address concerns such as lost facial volume, deep wrinkles, and improving the appearance of cellulite or skin laxity in various body areas. For best results and safety, always consult with a qualified professional.

Key Benefits

• Stimulates natural collagen production for gradual and long-lasting results.
• Restores lost volume and reduces the appearance of deep wrinkles and folds.
• Improves skin texture and elasticity for a more youthful look.
• Versatile treatment suitable for both facial and body contouring.
• Provides a natural-looking enhancement without an 'overfilled' appearance.

How to Use

1. Lanluma V must only be administered by a qualified and trained medical professional.
2. The product is supplied as a lyophilized powder and must be reconstituted with sterile water for injection prior to use.
3. The practitioner will assess the treatment area and determine the appropriate injection sites and volume.
4. A topical or local anesthetic may be applied to ensure patient comfort during the procedure.
5. Using a fine needle or cannula, Lanluma V is injected into the subdermal layer of the skin.
6. Following the injection, the treated area may be massaged to ensure even distribution of the product.
7. Multiple treatment sessions, typically spaced several weeks apart, may be required to achieve optimal results.

Caution & Warnings

• For professional use only. Must be administered by a licensed and trained healthcare practitioner.
• Not to be injected into blood vessels. Accidental intravascular injection can lead to serious adverse events.
• Do not use in patients with active skin infections, inflammation, or lesions in or near the treatment area.
• Avoid use in patients with a history of severe allergies, particularly to any of the product components.
• Pregnant or breastfeeding women should avoid treatment with Lanluma V.
• Potential side effects include redness, swelling, bruising, pain, and tenderness at the injection site.
• Rarely, nodules or granulomas may occur, which may require medical intervention.
• Always follow post-treatment care instructions provided by your practitioner.

Ingredients

Poly-L-lactic acid (PLLA) microparticles, carboxymethylcellulose (CMC), and non-pyrogenic mannitol.

Product Details

Lanluma V comes as a single vial containing 210 mg of lyophilized Poly-L-lactic acid powder. It requires reconstitution before use and is designed for subcutaneous or deep dermal injection to stimulate collagen and provide significant volumizing effects. Its unique formulation ensures a gradual and natural enhancement, making it a preferred choice for advanced aesthetic treatments.